![Jason Gross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 163 265 $ am 31.05.2026
Dr. Jason A. Gross is a Vice President-Scientific Affairs at HLS Therapeutics, Inc. Dr. Gross was previously employed as a Vice President-Scientific Affairs by Cipher Pharmaceuticals, Inc., a Vice President by MDS Capital Corp., a VP-Regulatory Affairs & Quality Assurance by Drugabuse Sciences, Inc., a Vice President-Scientific Affairs by HLS Therapeutics, Inc. /Old/, and a VP-Scientific & Medical Affairs by IVAX Pharmaceuticals, Inc. He received his doctorate degree from the University of Arizona.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.03.2025 | 49’700 ( 0.16% ) | 163 265 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HLS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2014 |
| Unternehmen | Position | Ende |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31.03.2006 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Corporate Officer/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Drugabuse Sciences, Inc. | General Counsel | - |
| CIPHER PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 7 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Drugabuse Sciences, Inc. | |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
